This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Protein Crystal Growth | |
|---|---|
| Name | Protein Crystal Growth |
| Field | Structural biology |
| Applications | X-ray crystallography, cryo-EM, drug design |
Protein Crystal Growth
Protein Crystal Growth concerns the ordered aggregation of protein molecules into crystalline lattices suitable for structural analysis. It underpins high-resolution techniques used by institutions such as Brookhaven National Laboratory, European Molecular Biology Laboratory, Max Planck Society, Lawrence Berkeley National Laboratory, and Stanford University in collaborations with facilities like Diamond Light Source and Advanced Photon Source. The discipline intersects with initiatives at organizations including National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, and programs supported by the National Science Foundation and European Research Council.
Protein crystal production serves as a preparative step for methods developed at places like Royal Institution and used by researchers affiliated with University of Cambridge, Massachusetts Institute of Technology, University of Oxford, Harvard University, and California Institute of Technology. Historically, progress involved laboratories connected to figures honored by awards such as the Nobel Prize in Chemistry and projects funded by entities such as the Gordon and Betty Moore Foundation and Bill & Melinda Gates Foundation. Major research centers including Argonne National Laboratory, Rutherford Appleton Laboratory, Scripps Research Institute, and Cold Spring Harbor Laboratory have maintained core facilities for crystallization alongside consortia like the Protein Data Bank depositors and the Structural Genomics Consortium.
The physical basis of crystalline assembly draws from thermodynamic and kinetic frameworks applied in studies at institutions like Imperial College London and ETH Zurich. Empirical phase diagrams and nucleation theories were developed in contexts involving researchers at Princeton University and Yale University and are used by teams collaborating with NASA microgravity programs and experiments aboard platforms such as the International Space Station. Crystallization relies on molecular recognition recorded by structures solved at facilities including European Synchrotron Radiation Facility, KEK, and National Synchrotron Light Source II.
Common methods such as hanging-drop, sitting-drop, dialysis, and microbatch have been refined in laboratories at University of Tokyo, Seoul National University, Weizmann Institute of Science, and University of California, San Francisco. High-throughput screening and robotics developed by companies and centers allied with EMBL-EBI, Genentech, Pfizer, Novartis, and GlaxoSmithKline enable combinatorial screens, while microfluidic devices originating from research groups at MIT Media Lab, ETH Zurich, and TU Delft allow controlled nucleation. Additives and fusion constructs inspired by studies at Columbia University, Johns Hopkins University, University of Chicago, and Brown University assist crystal packing, and seeding techniques trace developments linked to researchers associated with Max Planck Institute for Biophysical Chemistry.
Variables such as pH, ionic strength, precipitant type, and temperature are manipulated in projects at Los Alamos National Laboratory, Oak Ridge National Laboratory, University of British Columbia, and McGill University. Ligand binding and post-translational modifications addressed by teams at Massachusetts General Hospital, Mayo Clinic, Karolinska Institute, and Institut Pasteur influence lattice formation. Protein engineering strategies used by groups at Eli Lilly and Company, Bristol-Myers Squibb, Amgen, and Regeneron Pharmaceuticals often target surface entropy via mutations explored in collaborations with Broad Institute scientists.
Characterization workflows lead to data collection at synchrotrons such as SOLEIL, PETRA III, SPring-8, and APS and to analysis pipelines maintained by computing centers like European Grid Infrastructure, National Center for Supercomputing Applications, Lawrence Livermore National Laboratory, and Oak Ridge Leadership Computing Facility. Diffraction experiments employ detectors and software developed in partnerships involving Rigaku, Dectris, Bruker, and laboratories at University of Manchester. Complementary methods like cryo-electron microscopy used at MRC Laboratory of Molecular Biology and mass spectrometry at EMBL inform crystal validation.
Structures determined from crystals have driven discoveries at pharmaceutical and biotech organizations including Merck & Co., AstraZeneca, Sanofi, Bayer AG, Takeda Pharmaceutical Company, and biotechs emerging from University of California, Berkeley and Massachusetts Institute of Technology. Structural insights supported by crystal-derived models are central to programs like the Human Genome Project follow-ons, vaccine design efforts at Gavi, the Vaccine Alliance, and small-molecule optimization campaigns coordinated with agencies such as U.S. Food and Drug Administration and European Medicines Agency. Collaborative projects with nonprofits like Doctors Without Borders and foundations such as Wellcome Trust have used crystallography data to prioritize targets.
Persistent challenges are addressed in consortia and centers including Structural Genomics Consortium, RCSB PDB, Bioinformatics Institute, and national labs; these include recalcitrant membrane proteins studied at Memorial Sloan Kettering Cancer Center and multiprotein complexes targeted by teams at Fred Hutchinson Cancer Center. Advances leveraging machine learning from research groups at Google DeepMind, OpenAI, IBM Research, Microsoft Research, and university labs at Carnegie Mellon University and University of Toronto are transforming crystallization prediction and design. Innovations in serial crystallography, time-resolved studies at facilities like Linac Coherent Light Source, and integrative methods connecting data from European Molecular Biology Laboratory, Weizmann Institute of Science, and Scripps Research Institute continue to expand capabilities.